FDA Inspection 1272171 — Eurofins PROXY Laboratories B.V.
The FDA completed an inspection of Eurofins PROXY Laboratories B.V. on July 1, 2022 in Leiden. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- July 1, 2022
- Fiscal Year
- 2022
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Leiden (Netherlands)
Additional Details
Mutual Recognition Agreement (MRA)